IQE plc
Cardiff, UK
6 February 2024
Block Admission
IQE plc (AIM: IQE, "IQE" or the "Group"), the leading global supplier of compound semiconductor wafer products and advanced material solutions, today announces an application has been made to the London Stock Exchange for a block admission of 16,000,000 ordinary shares of 1p each in the Company ("Ordinary Shares") to trading on AIM, to satisfy obligations under the Company's existing Long Term Incentive Plan which was approved by shareholders in 2019. The Long Term Incentive Plan is currently used to incentivise all of IQE's employees on an annual basis.
The Ordinary Shares held under the block admission will be allotted and issued in due course in accordance with the rules of the respective scheme(s) and will rank pari passu in all respects with the existing Ordinary Shares in issue. It is expected that admission of the Ordinary Shares under the block admission will become effective at 8.00 am on 7 February 2024. The new Ordinary Shares will be added to the balance of 5,518,704 Ordinary Shares remaining from the previous block admission. There is no change to the Group's issued share capital as a result of the Block Admission.
Contacts:
IQE plc
+44 (0) 29 2083 9400
Americo Lemos
Jutta Meier
Amy Barlow
Peel Hunt (Nomad and Joint Broker)
+44 (0) 20 7418 8900
Paul Gillam
Richard Chambers
Kate Bannatyne
Deutsche Numis (Joint Broker)
+44 (0) 20 7260 1000
Simon Willis
Hugo Rubinstein
Iqra Amin
Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822
Andy Rivett-Carnac: +44 (0) 7968 997 365
Chloe Francklin: +44 (0)78 3497 4624
ABOUT IQE
IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:
· Smart Connected Devices
· Communications Infrastructure
· Automotive and Industrial
· Aerospace and Security
As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the global market and is enabling customers to innovate at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.
IQE is headquartered in Cardiff UK, with employees across eight manufacturing locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in London.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.